nr-axSpA

AbbVie seeks approval for upadacitinib to treat nr-axSpA
Pharmaceutical Business Review
Mon, 01/10/22 - 11:29 am
AbbVie
FDA
EMA
upadacatinib
nr-axSpA
non-radiographic axial spondyloarthritis